Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP534258.RA7qQWrfwUwcqzAEX2ChWDOk04B7F8a3F3e9CR9u9msIE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP534258.RA7qQWrfwUwcqzAEX2ChWDOk04B7F8a3F3e9CR9u9msIE130_assertion type Assertion NP534258.RA7qQWrfwUwcqzAEX2ChWDOk04B7F8a3F3e9CR9u9msIE130_head.
- NP534258.RA7qQWrfwUwcqzAEX2ChWDOk04B7F8a3F3e9CR9u9msIE130_assertion description "[Clinical trials of chimeric antigen receptor (CAR)-modified T cells have shown promise in hematologic malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP534258.RA7qQWrfwUwcqzAEX2ChWDOk04B7F8a3F3e9CR9u9msIE130_provenance.
- NP534258.RA7qQWrfwUwcqzAEX2ChWDOk04B7F8a3F3e9CR9u9msIE130_assertion evidence source_evidence_literature NP534258.RA7qQWrfwUwcqzAEX2ChWDOk04B7F8a3F3e9CR9u9msIE130_provenance.
- NP534258.RA7qQWrfwUwcqzAEX2ChWDOk04B7F8a3F3e9CR9u9msIE130_assertion SIO_000772 23256743 NP534258.RA7qQWrfwUwcqzAEX2ChWDOk04B7F8a3F3e9CR9u9msIE130_provenance.
- NP534258.RA7qQWrfwUwcqzAEX2ChWDOk04B7F8a3F3e9CR9u9msIE130_assertion wasDerivedFrom befree-20140225 NP534258.RA7qQWrfwUwcqzAEX2ChWDOk04B7F8a3F3e9CR9u9msIE130_provenance.
- NP534258.RA7qQWrfwUwcqzAEX2ChWDOk04B7F8a3F3e9CR9u9msIE130_assertion wasGeneratedBy ECO_0000203 NP534258.RA7qQWrfwUwcqzAEX2ChWDOk04B7F8a3F3e9CR9u9msIE130_provenance.